IGI Logo

Alembic Pharmaceuticals is currently trading at Rs. 827.55, up by 8.10 points or 0.99% from its previous closing of Rs. 819.45 on the BSE.

The scrip opened at Rs. 831.90 and has touched a high and low of Rs. 863.10 and Rs. 818.55 respectively. So far 75015 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1150.00 on 18-Dec-2020 and a 52 week low of Rs. 720.80 on 23-Aug-2021.

Last one week high and low of the scrip stood at Rs. 863.10 and Rs. 774.70 respectively. The current market cap of the company is Rs. 16230.22 crore.

The promoters holding in the company stood at 69.48%, while Institutions and Non-Institutions held 16.94% and 13.58% respectively.

Alembic Pharmaceuticals has received Establishment Inspection Report (EIR) from US Food and Drug Administration (USFDA) for the inspection carried out at New Injectable Facility (F-3) at Karakhadi, Gujarat during the period from January 28, 2021 to February 06, 2021, indicating that the USFDA finds company’s responses to their observations to be adequate. USFDA has also indicated that compliance verification would be performed during re-inspection of the said Facility in the next review cycle.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.